Proprietary AI analyst is now available

Tate & Lyle Valuation Multiples

Discover Tate & Lyle's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Indofood, The Marzetti, Tootsie Roll, Kent Gıda and more.

Tate & Lyle Overview

About Tate & Lyle

Tate & Lyle is a global provider of food and beverage ingredients and solutions. Following the sale of its commodity ingredients business, as well as its exit from the sugar business a decade earlier, Tate & Lyle is now focused on specialty ingredients—sweeteners, starches, specialty gums, and soluble fiber. It has nearly 5,000 employees and operates in over 120 countries, with most of its revenue generated in North America.


Founded

1903

HQ

United Kingdom

Employees

5.0K

Financials (LTM)

Revenue: $3B
EBITDA: $554M

EV

$4B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Tate & Lyle Financials

Tate & Lyle reported last 12-month revenue of $3B and EBITDA of $554M.

In the same LTM period, Tate & Lyle generated $1B in gross profit, $554M in EBITDA, and $240M in net income.

Revenue (LTM)


Tate & Lyle P&L

In the most recent fiscal year, Tate & Lyle reported revenue of $3B and EBITDA of $557M.

Tate & Lyle is profitable as of last fiscal year, with gross margin of 31%, EBITDA margin of 21%, and net margin of 9%.

See analyst estimates for Tate & Lyle
LTMLast FY202320242025202620272028
Revenue$3B$3B$2B$2B$3B
Gross Profit$1B$835M$959M$949M$863M
Gross Margin40%31%43%41%33%
EBITDA$554M$557M$441M$372M$448M
EBITDA Margin21%21%20%16%17%
EBIT Margin14%14%14%15%13%
Net Profit$240M$243M$253M$207M$146M
Net Margin9%9%11%9%6%
Net Debt-$1B---

Financial data powered by Morningstar, Inc.

Tate & Lyle Stock Performance

Tate & Lyle has current market cap of $3B, and enterprise value of $4B.

Market Cap Evolution


Tate & Lyle's stock price is $6.78.

Tate & Lyle share price decreased by 0.2% in the last 30 days, and by 1.7% in the last year.

Tate & Lyle has an EPS (earnings per share) of $0.55.

See more trading valuation data for Tate & Lyle
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$4B$3B0.7%-0.2%38.0%-1.7%$0.55

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Tate & Lyle Valuation Multiples

Tate & Lyle trades at 1.6x EV/Revenue multiple, and 7.7x EV/EBITDA.

See NTM and 2027E valuation multiples for Tate & Lyle

EV / Revenue (LTM)


Tate & Lyle Financial Valuation Multiples

As of June 5, 2026, Tate & Lyle has market cap of $3B and EV of $4B.

Tate & Lyle has a P/E ratio of 12.5x.

LTMLast FY202320242025202620272028
EV/Revenue1.6x1.6x1.9x1.9x1.6x
EV/EBITDA7.7x7.7x9.7x11.5x9.6x
EV/EBIT11.2x11.1x13.7x12.8x12.9x
EV/Gross Profit4.0x5.1x4.5x4.5x5.0x
P/E12.5x12.4x11.9x14.5x20.6x
EV/FCF24.6x26.2x45.2x56.1x35.6x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Tate & Lyle Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Tate & Lyle Margins & Growth Rates

Tate & Lyle grew revenue by 1% but EBITDA decreased by 2% in the last fiscal year.

In the most recent fiscal year, Tate & Lyle reported gross margin of 31%, EBITDA margin of 21%, and net margin of 9%.

See estimated margins and future growth rates for Tate & Lyle

Tate & Lyle Margins

Last FY202420252026202720282029
Gross Margin31%41%33%38%
EBITDA Margin21%16%17%20%
EBIT Margin14%15%13%13%
Net Margin9%9%6%7%
FCF Margin6%3%5%7%

Tate & Lyle Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth1%2%13%4%
Gross Profit Growth30%(1%)(9%)18%
EBITDA Growth(2%)(16%)21%18%
EBIT Growth(6%)7%(1%)7%
Net Profit Growth(7%)(18%)(30%)39%
FCF Growth36%(20%)58%68%

Data powered by FactSet, Inc. and Morningstar, Inc.

Tate & Lyle Operational KPIs

Tate & Lyle's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.1M for the same period.

Tate & Lyle's Rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Tate & Lyle's Rule of X is 29% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Tate & Lyle
LTMLast FY202320242025202620272028
Rule of 4022%23%---
Bessemer Rule of X23%29%---
Revenue per Employee-$0.5M---
Opex per Employee-$0.1M---
R&D Expenses to Revenue4%4%--4%
Opex to Revenue-19%29%27%20%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Tate & Lyle Competitors

Tate & Lyle competitors include Indofood, The Marzetti, Tootsie Roll, Kent Gıda, The Chefs' Warehouse, Ebro Foods, Suedzucker, National Beverage, a2 Milk and Maple Leaf Foods.

Most Tate & Lyle public comparables operate across Food & Beverages.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Indofood0.5x0.5x2.5x2.5x
The Marzetti1.4x1.4x9.4x9.0x
Tootsie Roll3.7x-17.5x-
Kent Gıda----
The Chefs' Warehouse1.0x0.9x15.6x14.8x
Ebro Foods1.0x1.0x5.9x7.0x
Suedzucker0.5x0.5x7.9x7.5x
National Beverage2.5x2.5x11.7x11.7x

This data is available for Pro users. Sign up to see all Tate & Lyle competitors and their valuation data.

Start Free Trial

Acquisitions by Tate & Lyle

Tate & Lyle has acquired 7 companies to date.

Last acquisition by Tate & Lyle was on June 20th 2024. Tate & Lyle acquired CP Kelco for $2B (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Tate & Lyle

CP Kelco
Nutriati
Quantum Hi-Tech China Biological
Sweet Green Fields
Description
CP Kelco is an Atlanta-headquartered producer of hydrocolloid ingredients including xanthan gum, carrageenan, pectin, and gellan gum for food, beverage, personal care, and industrial applications. The company supplies manufacturers in dairy, bakery, pharmaceuticals, and oilfield sectors worldwide from production sites in the US, Denmark, and Brazil. Products enhance texture, stability, and suspension in items like ice cream, sauces, and drilling fluids, with annual capacity exceeding 100,000 tons.
Nutriati is a U.S. firm that supplies functional chickpea-based ingredients including high-protein flour and protein isolate with clean taste profiles. These non-GMO, allergen-free products serve CPG manufacturers for applications in baked goods, pasta, snacks, plant-based meats, and beverages from its Illinois facility.
Quantum Hi-Tech China Biological is a Beijing-based producer of fructooligosaccharides derived from natural sources. The company manufactures FOS syrups and powders used as prebiotics in functional foods, beverages, and dietary supplements. It supplies domestic and international food processors with high-purity products compliant with health standards in China and export markets.
Sweet Green Fields is an Alamo, California-headquartered supplier of stevia leaf extracts. Pioneering high-purity rebaudiosides since 1999, it cultivates proprietary stevia varieties in China and Paraguay farms. The company provides Reb M isolates for beverages like Coca-Cola Zero Sugar, emphasizing low-bitterness profiles through patented purification processes.
HQ CountryUnited StatesUnited StatesChinaUnited States
HQ City
Atlanta, GA
Richmond, VA
Guangzhou
Seattle, WA
Deal Date20 Jun 20243 May 202231 Mar 20221 Dec 2020
Valuation$2B$13M$237M$75M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Tate & Lyle acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Tate & Lyle

When was Tate & Lyle founded?Tate & Lyle was founded in 1903.
Where is Tate & Lyle headquartered?Tate & Lyle is headquartered in United Kingdom.
How many employees does Tate & Lyle have?As of today, Tate & Lyle has over 5K employees.
Who is the CEO of Tate & Lyle?Tate & Lyle's CEO is Anthony Nicholas Hampton.
Is Tate & Lyle publicly listed?Yes, Tate & Lyle is a public company listed on London Stock Exchange.
What is the stock symbol of Tate & Lyle?Tate & Lyle trades under TATE ticker.
When did Tate & Lyle go public?Tate & Lyle went public in 1938.
Who are competitors of Tate & Lyle?Tate & Lyle main competitors include Indofood, The Marzetti, Tootsie Roll, Kent Gıda, The Chefs' Warehouse, Ebro Foods, Suedzucker, National Beverage, a2 Milk, Maple Leaf Foods.
What is the current market cap of Tate & Lyle?Tate & Lyle's current market cap is $3B.
What is the current revenue of Tate & Lyle?Tate & Lyle's last 12 months revenue is $3B.
What is the current revenue growth of Tate & Lyle?Tate & Lyle revenue growth (NTM/LTM) is 1%.
What is the current EV/Revenue multiple of Tate & Lyle?Current revenue multiple of Tate & Lyle is 1.6x.
What is the current EBITDA of Tate & Lyle?Tate & Lyle's last 12 months EBITDA is $554M.
What is Tate & Lyle's EBITDA margin?Tate & Lyle's last 12 months EBITDA margin is 21%.
What is the current EV/EBITDA multiple of Tate & Lyle?Current EBITDA multiple of Tate & Lyle is 7.7x.
What is the current FCF of Tate & Lyle?Tate & Lyle's last 12 months FCF is $174M.
What is Tate & Lyle's FCF margin?Tate & Lyle's last 12 months FCF margin is 6%.
What is the current EV/FCF multiple of Tate & Lyle?Current FCF multiple of Tate & Lyle is 24.6x.
How many companies Tate & Lyle has acquired to date?As of June 2026, Tate & Lyle has acquired 7 companies.
What was the largest acquisition by Tate & Lyle?$2B acquisition of CP Kelco on 20th June 2024 was the largest M&A Tate & Lyle has done to date.
In how many companies Tate & Lyle has invested to date?Tate & Lyle hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Tate & Lyle

Lists including Tate & Lyle

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial